Software-only products providing free-standing treatment represent a key healthcare opportunity for incumbents.
Social distancing may be necessary for two years or more. Here's where remote care comes into play.
The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.
In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.
It's time to get comfortable with being uncomfortable.
How to ensure medications work as intended for different patient populations.
A series of perspectives on the state of data in healthcare.
Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.
Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.
The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.